Quantcast

Latest Antitussives Stories

2010-11-19 10:11:00

SILVER SPRING, Md., Nov. 19, 2010 /PRNewswire-USNewswire/ -- Xanodyne Pharmaceuticals Inc., which makes Darvon and Darvocet, the brand version of the prescription pain medication propoxyphene, has agreed to withdraw the medication from the U.S. market at the request of the U.S. Food and Drug Administration. The FDA has also informed generic manufacturers of Xanodyne's decision and they will be removing their propoxyphene-containing products from the market as well. (Logo:...

2010-10-19 07:37:17

On the heels of an FDA Advisory Committee Meeting evaluating safety concerns of cold medication dextromethorphan, Buster Brands announces Cold Buster, a new product with proven efficacy and no risks of abuse. Morristown, NJ (Vocus) October 19, 2010 (Vocus) October 19, 2010 -- On September 14, 2010, the FDA Drug Safety and Risk Management Advisory Committee met to evaluate the safety of dextromethorphan, a popular cough suppressant contained in approximately 125 over-the-counter...

2010-10-08 08:08:47

(Ivanhoe Newswire) -- It might be painful but it's time to say good riddance to codeine as a pain reliever. Codeine is used to relieve mild to moderate pain and it has been used for that purpose for more than 20 years. When it's used to treat pain, it works by changing the way the body senses pain. But because of its significant risks and ineffectiveness as an analgesic, physicians want to limit the use of the medication. Codeine has never been subjected to the rigorous regulatory and safety...

2010-09-17 15:56:00

NEWTOWN SQUARE, Pa., Sept. 17 /PRNewswire/ -- Launching now in national pharmacy chains is Chestal®, a natural cough syrup free of dextromethorphan from Boiron, the world leader in homeopathic medicines. This introduction comes on the heels of the success of Chestal's counterpart, Children's Chestal®, which was launched two years ago amid concerns over the safety of other active cough syrup ingredients for small children. Boiron, with a 78-year history of...

2010-09-14 17:54:00

WASHINGTON, Sept. 14 /PRNewswire-USNewswire/ -- The Consumer Healthcare Products Association issued the following statement on the Drug Safety and Risk Management Advisory Committee's recommendation not to schedule over-the-counter (OTC) medicines containing dextromethorphan: "Today's FDA advisory committee decision not to recommend scheduling OTC cough medicines containing dextromethorphan as a controlled substance reflects a sound balancing of the benefits of over-the-counter medicines...

2010-09-14 07:56:00

Survey of Police and Teachers: Alcohol and Marijuana Most Serious Substance Abuse Facing Teens NEW YORK, Sept. 14 /PRNewswire-USNewswire/ -- The Center for Medicine in the Public Interest released the results of a national Teen Substance Abuse survey today, indicating that police officers and high school teachers nationwide believe alcohol and marijuana are the most serious problem substances facing teenagers. These survey results come as the Food and Drug Administration has scheduled an...

2010-09-09 10:02:00

Upcoming FDA Hearing on Abuse of Cough and Cold Medications Misses the Mark NEW YORK, Sept. 9 /PRNewswire-USNewswire/ -- The Center for Medicine in the Public Interest released the results of a national Teen Substance Abuse survey today, indicating that police officers and high school teachers nationwide believe alcohol and marijuana are the most serious problem substances facing teenagers. These survey results come as the Food and Drug Administration has scheduled an Advisory Committee...

303565b13a27a6ef7d24734294bb5f24
2010-09-01 08:10:00

US health regulators are working out possible restrictions on popular cough suppressants in hopes to stop cases of abuse that send thousands of people to the hospital each year. The Food and Drug Administration posted its review on Tuesday of dextromethorphan, an ingredient found in over a hundred non-prescription medications that is often abused for its euphoric effects. "Robotripping," as it is known among abusers, involves taking more than 25 times the recommended dosage of a cold...

2010-07-16 12:33:00

HALIFAX, Canada, July 16, 2010 /PRNewswire-FirstCall/ -- Gammon Gold Inc. ("Gammon") (TSX:GAM and NYSE:GRS): Gammon is pleased to announce that it has completed the non-brokered private placement with Corex Gold Corporation ("Corex") (TSXV:CGE) announced on July 8, 2010. Pursuant to the private placement, Gammon has acquired 4,706,000 units of Corex at a subscription price of CAD $0.68 per unit for an aggregate purchase price of CAD $3,200,080, representing approximately 12% of the issued...

2010-07-08 10:57:00

HALIFAX, Canada, July 8, 2010 /PRNewswire-FirstCall/ -- - TSX: GAM / NYSE: GRS / BSX: GL7 Gammon Gold Inc. ("Gammon") (TSX:GAM and NYSE:GRS): Gammon is pleased to announce that it has entered into an agreement with Corex Gold Corporation ("Corex") (TSX-V: CGE) to acquire 4,706,000 units of Corex pursuant to a non- brokered private placement. Each unit consists of one common share and one half of one share purchase warrant exercisable at CAD $0.90 for a period of 24 months from...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related